Moderna's COVID-19 vaccine trial in pregnant women should 'reassure' public, expert says

Moderna's move to launch a study of its COVID-19 vaccine in pregnant women should reassure the public and help build confidence in the jab's safety, experts said.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.